TTTatsuaki Tsuruyama

Tatsuaki Tsuruyama

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tatsuaki Tsuruyama has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Bile canalicular abnormalities in the early phase of a mouse model of sclerosing cholangitis

    by Masashi Miyao, Munetaka Ozeki, Hitoshi Abiru, Sho Manabe, Hirokazu Kotani, Tatsuaki Tsuruyama, Keiji Tamaki


  • Open Access

    PD-1 Regulates the Growth of Human Mastocytosis Cells

    by Tatsuki R. Kataoka, Masakazu Fujimoto, Koki Moriyoshi, Itsuko Koyanagi, Chiyuki Ueshima, Fumihiko Kono, Tatsuaki Tsuruyama, Yoshimichi Okayama, Chisei Ra, Hironori Haga

    BackgroundProgrammed death-1 (PD-1) is a marker for human neoplastic T cells. Here, we evaluated whether or not PD-1 was also a marker for human mastocytosis, and explored the role of PD-1 in human mastocytosis cells.MethodsImmunohistochemical analysis was used to evaluate the expression of PD-1 in clinical samples of human cutaneous mastocytosis. The expression of PD-1 in human mastocytosis cell lines was checked by RT- PCR, western blotting and flow cytometry. We stimulated human mastocytosis cell lines (LAD2 and HMC1.2) with recombinant ligand for PD-1, PD-L1 (rPD-L1), and tested the proliferative activity and the status of signal molecules by Cell Counting Kit-8 and ELISA, respectively.ResultsTen of 30 human cutaneous mastocytosis cases (33.3%) expressed PD-1 protein. We also found that a human mastocytosis line LAD2 cells expressed PD-1 protein on their surfaces. The administration with rPD-L1 suppressed the stem cell factor-dependent growth of the LAD2 cells. And, rPD-L1 activated SHP-1 and SHP-2 simultaneously, and decreased the phosphorylation of AKT, in LAD2 cells. In contrast, we could not detect the expression of PD-1, and the significant effect of rPD-L1 on the mutated KIT-driven growth of HMC1.2 cells.ConclusionsPD-1 could be a marker for human cutaneous mastocytosis and regulate the growth of human PD-1-positive mastocytosis cells


  • Open Access

    Novel In Situ Pretreatment Method for Significantly Enhancing the Signal In MALDI-TOF MS of Formalin-Fixed Paraffin-Embedded Tissue Sections

    by Yu Kakimoto, Tatsuaki Tsuruyama, Takushi Yamamoto, Masaru Furuta, Hirokazu Kotani, Munetaka Ozeki, Akihiko Yoshizawa, Hironori Haga, Keiji Tamaki

    The application of matrix-assisted laser desorption/ionization (MALDI)-based mass spectrometry (MS) to the proteomic analysis of formalin-fixed paraffin-embedded (FFPE) tissue presents significant technical challenges. In situ enzymatic digestion is frequently used to unlock formalin-fixed tissues for analysis, but the results are often unsatisfactory. Here, we report a new, simplified in situ pretreatment method for preparing tissue sections for MS that involves heating with vapor containing acetonitrile in a small airtight pressurized space. The utility of the novel method is shown using FFPE tissue of human colon carcinoma. The number and intensity of MALDI peaks obtained from analysis of pretreated tissue was significantly higher than control tissue not subjected to pretreatment. A prominent peak (m/z 850) apparently specific to cancerous tissue was identified as a fragment of histone H2A in FFPE tissue pretreated using our method. This highly sensitive treatment may enable MALDI-MS analysis of archived pathological FFPE samples, thus leading to the identification of new biomarkers.